Saturday, 19 November 2011

F.D.A. Revokes Approval of Avastin for Use as Breast Cancer Drug

The commissioner, Dr. Margaret A. Hamburg, said that clinical trials had shown that the drug was not helping breast cancer patients to live longer or to meaningfully control their tumors, but did expose them to potentially serious side effects like severe high blood pressure and hemorrhaging ...


Related News:-

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...